Mutant prevention concentration and phenotypic and molecular basis of fluoroquinolone resistance in clinical isolates and in vitro-selected mutants of Escherichia coli from dogs
Authors:
- Dereje DamteDDDereje Damte
- Myung-Jin ChoiMCMyung-Jin Choi
- Seung-Jin LeeSLSeung-Jin Lee
- Young-Hoan KimYKYoung-Hoan Kim
- Seung Chun ParkSPSeung Chun Park
- 27 January 2012
- journal article
- Published by Elsevier in Veterinary Microbiology
- Vol. 154 (3-4) , 384-394
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Influence of Inoculum Size on the Selection of Resistant Mutants of Escherichia coli in Relation to Mutant Prevention Concentrations of MarbofloxacinAntimicrobial Agents and Chemotherapy, 2007
- Mutant Selection Window Hypothesis UpdatedClinical Infectious Diseases, 2007
- Trends in Fluoroquinolone Resistance of Bacteria Isolated from Canine Urinary TractsJournal of Veterinary Diagnostic Investigation, 2003
- In Vitro Pharmacodynamic Evaluation of the Mutant Selection Window Hypothesis Using Four Fluoroquinolones against Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2003
- Simulated in vitro Quinolone Pharmacodynamics at Clinically Achievable AUC/MIC Ratios: Advantage of IE over Other Integral ParametersChemotherapy, 2002
- Mutation in the DNA Gyrase A Gene of Escherichia coli That Expands the Quinolone Resistance-Determining RegionAntimicrobial Agents and Chemotherapy, 2001
- Comparative pharmacodynamics of moxifloxacin and levofloxacin in an in vitro dynamic model: prediction of the equivalent AUC/MIC breakpoints and equiefficient doses.Journal of Antimicrobial Chemotherapy, 2000
- Comparison of fluoroquinolone pharmacokinetic parameters after treatment with marbofloxacin, enrofloxacin, and difloxacin in dogsJournal of Veterinary Pharmacology and Therapeutics, 2000
- Mutant Prevention Concentration as a Measure of Antibiotic Potency: Studies with Clinical Isolates of Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2000
- Efficacy of intermittent versus continuous administration of netilmicin in a two-compartment in vitro modelAntimicrobial Agents and Chemotherapy, 1985